Qiagen acquires Sawady for $18 million

Qiagen (QGENF; NMarkt:QIA) acquired the synthetic nucleic acid provider Sawady Group (Tokyo, Japan) for 854,987 shares valued at $18 million. QGENF said it will incur $3 million in charges related to ...